Ladenburg Thalmann Financial Services’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$6K	Hold	135	–	–	﹤0.01%	4730
2019 Q3	$2K	Hold	135	–	–	﹤0.01%	5022
2019 Q2	$5K	Buy	135 +2	+2%	+$108	﹤0.01%	4735
2019 Q1	$7K	Sell	133 -2	-1%	-$108	﹤0.01%	4551
2018 Q4	$6K	Buy	135 +2	+2%	+$110	﹤0.01%	4533
2018 Q3	$10K	Sell	133 -67	-34%	-$4.42K	﹤0.01%	4305
2018 Q2	$21K	Hold	200	–	–	﹤0.01%	3809
2018 Q1	$21K	Hold	200	–	–	﹤0.01%	3809
2017 Q4	$26K	Hold	200	–	–	﹤0.01%	3630
2017 Q3	$23K	Buy	+200	New	+$24K	﹤0.01%	3604

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Ladenburg Thalmann Financial Services's VBIV Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) position steady in Q4 2019 at 135 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4730.

Ladenburg Thalmann Financial Services first reported a position in VBIV in Q3 2017 and has held it in 10 quarters since. The position peaked at $26K in Q4 2017. 75 funds tracked by Wall St. Rank hold VBIV as of Q4 2019.

Ladenburg Thalmann Financial Services held 135 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $6K as of Q4 2019.
Ladenburg Thalmann Financial Services left its VBI Vaccines, Inc. New Common Stock (Canada) share count unchanged in Q4 2019.
VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4730 holding.
Ladenburg Thalmann Financial Services first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2017 and has held it in 10 quarters since.
Ladenburg Thalmann Financial Services's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $26K in Q4 2017.
75 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.